NEW PRODUCT LAUNCH & LIFE CYCLE MANAGEMENT
Here is a set of self-assessment questions:
Has the differential (tangible / intangible) for the new product been competitively well-positioned to drive the maximum change to Rx switch?
Has the growth strategy of the new product for its ‘1st phase’ considered adequate synchronization between patient profile and customer clientele?
Is the analytics to diagnose brand stagnancy, driven solely by quantitative data of sales and Rx trend?
Do we measure, track and set objective for big brands considering its share / penetration into various segments / sub-segments / profiles of patients?
Our Approach
WhiteSpace helps in establishing a systematic all comprehensive marketing process to introduce 'New Products' to achieve value maximization and the most coveted market position and also helps in designing most suited strategy to re-enthuse brand buoyancy despite apparent maturity / decline / stagnancy.
VIEW OTHER PILLARS OF MARKETING EXCELLENCE
